文献速递神经免疫

多发性硬化患者前驱期精神疾病共病研究

Psychiatric Comorbidity During the Prodromal Period in Patients With Multiple Sclerosis.
PubMed 文献 · Neurology · 2023-09-25

本研究基于加拿大不列颠哥伦比亚省行政与临床数据,比较多发性硬化(MS)患者与匹配对照在MS起病前5年的精神疾病患病率及负担。行政队列中28.0%病例与14.9%对照有精神疾病,患病率比1.91(95%CI 1.83-2.00);临床队列为22.0% vs 14.1%,患病率比1.58(95%CI 1.38-1.81)。行政队列中病例在起病前各年医疗服务使用均更高,临床队列结果不显著。

要点

  • MS起病前5年精神疾病患病率:行政队列病例28.0% vs 对照14.9%,患病率比1.91(95%CI 1.83-2.00)。
  • 临床队列病例22.0% vs 对照14.1%,患病率比1.58(95%CI 1.38-1.81)。
  • 行政队列病例起病前精神科就诊、住院及精神药物配药均高于对照,临床队列结果不显著。

核心结论

  • 精神疾病在MS起病前即构成显著负担,可能是MS前驱期的特征之一。

研究设计与样本

  • 利用加拿大不列颠哥伦比亚省链接的行政与临床数据,通过验证算法或神经科医生诊断的MS门诊患者识别病例,按年龄、性别和地理位置与最多5名一般人群对照匹配。
  • 行政队列包含6,863例病例和31,865名对照;临床队列包含966例病例和4,534名对照。
  • 通过验证定义识别精神疾病,比较MS首次脱髓鞘索赔(行政队列)或症状起病(临床队列)前5年的患病率,并估计病例/对照患病率比及95%CI。
  • 使用负 binomial 回归通过广义估计方程比较起病前每年精神疾病相关医生就诊、精神科就诊、精神相关住院及精神药物配药,结果报告为调整率比及95%CI。

主要发现

  • 行政队列起病前5年内,28.0%(1,920/6,863)病例和14.9%(4,738/31,865)对照有精神疾病;临床队列为22.0%(213/966)病例和14.1%(638/4,534)对照。
  • 精神疾病患病率比从1.58(95%CI 1.38-1.81,临床队列)到1.91(95%CI 1.83-2.00,行政队列)。
  • 行政队列中,病例起病前每年医疗服务使用均更高(所有95%CI >1):起病前第5年医生就诊高78%,起病前1年高124%;精神科就诊第5年高132%,第1年高146%;住院第5年高129%,第1年高197%;处方配药第5年高72%,第1年高100%。
  • 临床队列中上述结果不显著。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Psychiatric morbidity is common after a multiple sclerosis (MS) diagnosis. However, little is known about psychiatric comorbidity during the prodromal phase (before MS onset). To compare the prevalence and relative burden of psychiatric morbidity in individuals with MS with matched controls before MS onset. METHODS: Using linked administrative and clinical data from British Columbia, Canada, we identified cases with MS through a validated algorithm or from neurologist-diagnosed MS clinic attendees. Cases were matched by age, sex, and geographical location with up to 5 general population controls. We identified psychiatric morbidity through a validated definition and determined its prevalence in cases/controls in the 5 years before the first demyelinating claim of cases with MS ("administrative cohort") or symptom onset ("clinical cohort") and estimated case/control prevalence ratios with 95% CIs. We also compared the yearly number of physician visits for psychiatric morbidity, visits to psychiatrists, psychiatric-related admissions, and psychotropic dispensations pre-MS onset in cases/controls regardless of whether psychiatric morbidity algorithm was fulfilled using negative binomial regression fitted through generalized estimating equations; results were reported as adjusted rate ratios with 95% CIs. We assessed yearly trends through interaction terms between cases/controls and each year pre-MS onset. RESULTS: The administrative cohort comprised 6,863/31,865 cases/controls; the clinical cohort comprised 966/4,534 cases/controls. Over the entire 5-year period pre-MS onset, 28.0% (1,920/6,863) of cases and 14.9% (4,738/31,865) of controls (administrative cohort) had psychiatric morbidity, as did 22.0% (213/966) of clinical cases and 14.1% (638/4,534) controls. Psychiatric morbidity prevalence ratios ranged from 1.58; 95% CI 1.38-1.81 (clinical cohort) to 1.91; 95% CI 1.83-2.00 (administrative cohort). In the administrative cohort, health care use was higher for cases in each year pre-MS onset (all 95% CIs >1); physician visits were 78% higher in year 5 pre-MS onset and 124% 1 year before; visits to psychiatrists were 132% higher in year 5 and 146% in year 1; hospitalizations were 129% higher in year 5 and 197% in year 1; and prescription dispensations were 72% higher in year 5 and 100% in year 1. Results were not significant in the clinical cohort. DISCUSSION: Psychiatric morbidity represents a significant burden before MS onset and may be a feature of the MS prodrome.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Chertcoff AS, Yusuf FLA, Zhu F, et al. Psychiatric Comorbidity During the Prodromal Period in Patients With Multiple Sclerosis. Neurology. 2023. PMID: 37748884. doi:10.1212/WNL.0000000000207843

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。